Bhalchandra V. Joshi

Person

Rockville, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Immunotherapeutic tumor treatment method
- Patent number 12,054,553
- Issue date Aug 6, 2024
- Nektar Therapeutics
- Saul Kivimae
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunotherapeutic tumor treatment method
- Patent number 12,030,940
- Issue date Jul 9, 2024
- Nektar Therapeutics
- Jonathan Zalevsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acid salt forms of polymer-drug conjugates and alkoxylation methods
- Patent number 9,320,808
- Issue date Apr 26, 2016
- Nektar Therapeutics
- Anthony O. Chong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt form of a multi-arm polymer-drug conjugate
- Patent number 9,226,969
- Issue date Jan 5, 2016
- Nektar Therapeutics
- Anthony O. Chong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods to treat cardiac diseases
- Patent number 8,822,434
- Issue date Sep 2, 2014
- The University of Connecticut
- Bruce Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purine derivatives as A3 and A1 adenosine receptor agonists
- Patent number 7,825,126
- Issue date Nov 2, 2010
- The United States of America as represented by the Department of Health and H...
- Kenneth A. Jacobson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD
- Publication number 20210292425
- Publication date Sep 23, 2021
- Nektar Therapeutics
- Saul Kivimae
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-ARM POLYMER CONJUGATES OF TLR AGONIST COMPOUNDS AND RELATED I...
- Publication number 20210128737
- Publication date May 6, 2021
- Zhongxu Ren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD
- Publication number 20210130467
- Publication date May 6, 2021
- Nektar Therapeutics
- Jonathan Zalevsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACID SALT FORMS OF POLYMER-DRUG CONJUGATES AND ALKOXYLATION METHODS
- Publication number 20150105519
- Publication date Apr 16, 2015
- Nektar Therapeutics
- Anthony O. Chong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salt Form of a Multi-Arm Polymer-Drug Conjugate
- Publication number 20130231359
- Publication date Sep 5, 2013
- Nektar Therapeutics
- Anthony O. Chong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acid Salt Forms of Polymer-Drug Conjugates and Alkoxylation Methods
- Publication number 20130143909
- Publication date Jun 6, 2013
- Nektar Therapeutics
- Anthony O. Chong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES
- Publication number 20110212924
- Publication date Sep 1, 2011
- Bruce Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Purine Derivatives as A3 and A1 Adenosine Receptor Agonists
- Publication number 20070232626
- Publication date Oct 4, 2007
- GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEP...
- Kenneth A. Jacobson
- C07 - ORGANIC CHEMISTRY

Bhalchandra V. Joshi

Person

Patents Grantslast 30 patents

Immunotherapeutic tumor treatment method

Immunotherapeutic tumor treatment method

Acid salt forms of polymer-drug conjugates and alkoxylation methods

Salt form of a multi-arm polymer-drug conjugate

Compositions and methods to treat cardiac diseases

Purine derivatives as A3 and A1 adenosine receptor agonists

Patents Applicationslast 30 patents

IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD

MULTI-ARM POLYMER CONJUGATES OF TLR AGONIST COMPOUNDS AND RELATED I...

IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD

ACID SALT FORMS OF POLYMER-DRUG CONJUGATES AND ALKOXYLATION METHODS

Salt Form of a Multi-Arm Polymer-Drug Conjugate

Acid Salt Forms of Polymer-Drug Conjugates and Alkoxylation Methods

COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES

Purine Derivatives as A3 and A1 Adenosine Receptor Agonists